Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

Published:2014-02-28 Issue:4 Volume:59 Page:1577-1590
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fuchs Bryan C.¹,Hoshida Yujin²,Fujii Tsutomu¹,Wei Lan¹,Yamada Suguru¹,Lauwers Gregory Y.³,McGinn Christopher M.⁴,DePeralta Danielle K.¹,Chen Xintong²,Kuroda Toshihiko¹,Lanuti Michael⁴,Schmitt Anthony D.⁴,Gupta Supriya⁵,Crenshaw Andrew⁵,Onofrio Robert⁵,Taylor Bradley⁵,Winckler Wendy⁵,Bardeesy Nabeel⁶,Caravan Peter⁷,Golub Todd R.⁸⁹¹⁰,Tanabe Kenneth K.¹

Affiliation:

1. Division of Surgical Oncology; Massachusetts General Hospital Cancer Center and Harvard Medical School; Boston MA

2. Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine; Icahn School of Medicine at Mount Sinai; New York NY

3. Department of Pathology; Massachusetts General Hospital Cancer Center and Harvard Medical School; Boston MA

4. Division of Thoracic Surgery; Massachusetts General Hospital Cancer Center and Harvard Medical School; Boston MA

5. Genetic Analysis Platform; Broad Institute; Cambridge MA

6. Department of Medicine; Massachusetts General Hospital Cancer Center and Harvard Medical School; Boston MA

7. A.A. Martinos Center for Biomedical Imaging, Department of Radiology; Massachusetts General Hospital and Harvard Medical School; Charlestown MA

8. Cancer Program; Broad Institute; Cambridge MA

9. Dana-Farber Cancer Institute and Harvard Medical School; Boston MA

10. Howard Hughes Medical Institute; Boston MA

Funder

Mount Sinai School of Medicine, New York, NY

Publisher

Wiley